Cibus, Inc - שינוי בהכנסות משנה לשנה ב-12 החודשים האחרונים CBUS

Cibus, Inc. (CBUS) ensures revenue stability by implementing precise gene modifications across various crops, which mitigates climate risks. The year-over-year sales trend over the last 12 months clearly demonstrates this momentum, with the value holding at 19.80. Cibus, Inc. (CBUS) is actively developing synergies with seed farms, prioritizing the licensing of its bio-innovations to the industry's largest holdings.
פילוחי נתונים אנליטיים מרוכזים עבור Cibus Global (CBUS)

Fundamental asset screening requires separating market noise from actual business dynamics. This indicator measures the percentage revenue growth over a rolling year, neutralizing seasonal fluctuations by comparing TTM periods. By analyzing the 12-month YoY revenue growth chart, an investor assesses the sustainability of cash flow. For Cibus, Inc. (CBUS), this metric reflects the commercialization pace of genome editing innovations. Growth in this indicator confirms the demand for sustainable crops within the agricultural sector.